Form 13-F position report

HERBALIFE NUTRITION LTD

Reported by Pekin Hardy Strauss Inc

HLF CUSIP G4412G101 Manager CIK 0001020317

Reported 205,051 shares, up 26,040 (14.5%) from the prior quarter.

Reported value -7.9%; share count 14.5% vs. the prior quarter.

Added
% of reported 13F value 1.24% This manager · Q3 2021
Shares 205,051 Quarter-end amount reported
Reported value $8,690,000 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 8690000
2021-12-31 10579000
2022-03-31 7983000
2022-06-30 5392000
2022-09-30 5841000
2022-12-31 4694923
2023-03-31 4603537
2023-06-30 4158605
2023-09-30 3974685
2023-12-31 4130333
2024-03-31 2979453
2024-06-30 3545099
2024-09-30 3568828
2024-12-31 3245018
2025-03-31 3305989
2025-06-30 3768500
2025-09-30 3601196
2025-12-31 3721652
2026-03-31 4194906
2026-06-30 4129021

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for HERBALIFE NUTRITION LTD held by Pekin Hardy Strauss Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 313,994 +29,014 (10.2%) 0.36% $4,129,021 2026-07-30
Q1 2026 Reduced 284,980 -3,744 (-1.3%) 0.44% $4,194,906 2026-05-07
Q4 2025 Reduced 288,724 -137,958 (-32.3%) 0.34% $3,721,652 2026-01-30
Q3 2025 Reduced 426,682 -10,499 (-2.4%) 0.36% $3,601,196 2025-11-10
Q2 2025 Added 437,181 +54,100 (14.1%) 0.43% $3,768,500 2025-08-06
Q1 2025 Reduced 383,081 -101,974 (-21.0%) 0.4% $3,305,989 2025-04-30
Q4 2024 Reduced 485,055 -11,305 (-2.3%) 0.41% $3,245,018 2025-02-04
Q3 2024 Added 496,360 +155,157 (45.5%) 0.46% $3,568,828 2024-11-12
Q2 2024 Added 341,203 +44,740 (15.1%) 0.49% $3,545,099 2024-08-09
Q1 2024 Added 296,463 +25,799 (9.5%) 0.41% $2,979,453 2024-05-03
Q4 2023 Reduced 270,664 -13,445 (-4.7%) 0.58% $4,130,333 2024-02-05
Q3 2023 Reduced 284,109 -29,985 (-9.5%) 0.63% $3,974,685 2023-11-08
Q2 2023 Added 314,094 +28,160 (9.8%) 0.46% $4,158,605 2023-08-08
Q1 2023 Reduced 285,934 -29,585 (-9.4%) 0.61% $4,603,537 2023-05-08
Q4 2022 Added 315,519 +21,848 (7.4%) 0.65% $4,694,923 2023-02-13
Q3 2022 Added 293,671 +30,015 (11.4%) 0.93% $5,841,000 2022-11-09
Q2 2022 Added 263,656 +700 (0.3%) 0.76% $5,392,000 2022-08-05
Q1 2022 Added 262,956 +4,490 (1.7%) 0.99% $7,983,000 2022-05-13
Q4 2021 Added 258,466 +53,415 (26.0%) 1.43% $10,579,000 2022-02-08
Q3 2021 Added 205,051 +26,040 (14.5%) 1.24% $8,690,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

265 managers reported HERBALIFE NUTRITION LTD for Q3 2021.

Managers reporting HERBALIFE NUTRITION LTD in Q3 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Capital Research Global Investors Reduced 12,797,129 -5,611,072 0.13% $542,370,000 20 qtrs
VANGUARD GROUP INC Added 11,368,684 +137,318 0.01% $481,804,000 34 qtrs
Route One Investment Company L P Added 8,791,232 +858,678 9.59% $372,572,000 28 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 8,748,564 -146,100 0.48% $370,764,000 25 qtrs
FMR LLC Reduced 6,090,600 -893,370 0.02% $258,120,000 34 qtrs
Alua Capital Management LP Unchanged 5,214,694 0 11.4% $220,999,000 4 qtrs
BlackRock Inc Reduced 4,185,054 -899,686 < 0.01% $177,363,000 34 qtrs
Deccan Value Investors L P Added 3,745,293 +780,218 6.28% $158,726,000 27 qtrs
CAS Investment Partners LLC Added 2,996,462 +1,000,000 6.05% $126,990,000 16 qtrs
Bronte Capital Management Pty Ltd Added 2,345,486 +91,625 7.27% $99,402,000 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2021
Filed
November 12, 2021
Filing type
13F-HR
Position type
COM SHS

Voting authority reported

Sole
77,000
Shared
0
None
128,051

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.